Introduction: Management of anaphylaxis in Emergency Departments often is not in keeping with guidelines. We aimed to examine anaphylaxis presentations to our tertiary Emergency Department to determine adherence to local protocol of management of anaphylaxis, as well as rate of referral to quaternary immunology services.
• 133 (88.6%) received treatment prior to hospital, with 71 receiving adrenaline prior to ambulance arrival and 44 receiving adrenaline by paramedics.
• There was a low threshold to use adrenaline, with 25 patients given adrenaline in the Emergency Department without documented evidence of anaphylaxis.
• Of those who received adrenaline intramuscularly in the Emergency Department, it was the initial treatment in 94.7%.
• 65 presentations were due to a previously known allergen, with anaphylaxis to tree nuts and peanut accounting for 36.9% and 23% of cases, respectively.
• 77.3% were observed for >4 hours post adrenaline.
• 26 (17.3%) were not prescribed an adrenaline autoinjector on discharge, where in 6 cases it was indicated.
• 95 (63.3%) were not referred to an immunologist; 54 had known allergy, but was not documented if known to an immunologist, and 23 were not referred after their first episode of anaphylaxis.
Conclusion:
Our Emergency Department has high adherence to our anaphylaxis protocol in the initial resuscitation, but there are gaps in communication and referral to specialist immunology clinics.
P37 MORE ADRENALINE FOR ANAPHYLAXIS OVER THE LAST DECADE?
Kristina Rueter Conclusion: There was a significant improvement in the management of anaphylaxis over this 10-year period. This appeared to be related to an intensified physician training program and highlights the importance of cooperation between paediatric emergency and allergy services. 
